Clinical Trial Update: Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant immunotherapy trial in early-stage non-small cell lung cancer presenting as synchronous ground-glass nodules has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: XiangNing Fu | Conditions: Multiple Pulmonary Nodules | Phase 2 | Status: COMPLETED